AISAP Cardio vs AI-ECG Tracker
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your primary need is rapid, AI-powered point-of-care ultrasound for comprehensive cardiac diagnostic assessments directly at the patient's bedside. This tool is ideal for early detection and quantification of structural heart disease and heart failure, providing immediate visual and quantitative data on valvular pathologies and ventricular function.
View AISAP Cardio →Choose AI-ECG Tracker if…
Choose AI-ECG Tracker if your focus is on highly accurate, AI-powered automated interpretation of 12-lead ECG data for a wide spectrum of common cardiac abnormalities. This solution is best suited for scenarios requiring rapid diagnosis (approximately 3 seconds) of conditions like arrhythmias, myocardial ischemia, and ventricular hypertrophy, supporting efficient initial assessment and triage.
View AI-ECG Tracker →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | AI-ECG Tracker |
|---|---|---|
| Pricing | Unknown | Not publicly available |
| Deployment | Cloud-based | On-premise (AI-ECG Workstation, Diagnostic Client) with optional cloud service (Lepu Nebula Cloud) for remote diagnostic services. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for point-of-care ultrasound, enabling rapid, bedside diagnostics and empowering clinicians with basic scanning skills to accurately interpret echocardiograms within minutes. Its real-time guidance feature and short training time enhance usability for a broad range of users, including non-cardiologists.
Clinical Value
AISAP CardioWhile both tools are FDA-cleared and offer high accuracy in their respective domains, AISAP Cardio provides immediate, comprehensive structural cardiac assessments at the point of care. This empowers non-cardiologists with expert-level diagnostic accuracy for critical conditions like structural heart disease and heart failure, significantly expanding access to advanced diagnostics.
Pricing & Value
TieNeither AISAP Cardio nor AI-ECG Tracker publicly discloses pricing information. Without transparent pricing details for either solution, it is impossible to conduct a head-to-head comparison of their value propositions.
Enterprise Readiness
AISAP CardioAISAP Cardio operates as a cloud-based SaaS platform, explicitly stating it is vendor-agnostic, scalable, and integrates seamlessly with existing clinical workflows, EHR/EMR, and PACS technologies. It also highlights HIPAA-compliant and ISO-certified cloud infrastructure, indicating a robust readiness for enterprise deployment and data handling.
Innovation
AISAP CardioAISAP Cardio demonstrates higher innovation by being the first company globally to secure FDA clearance in the CADx pathway for comprehensive structural heart disease diagnosis using point-of-care ultrasound. This application of AI to POCUS for real-time, bedside structural heart disease detection represents a significant advancement in democratizing advanced cardiac diagnostics.
Support & Docs
AI-ECG TrackerWhile specific support for the AI-ECG Tracker is not extensively detailed, its parent company, Shenzhen Carewell Electronics Co., provides general contact information and has demonstrated customer support for related products. AISAP Cardio does not have publicly available information regarding its support channels or documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | AI-ECG Tracker |
|---|---|---|
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI technology for ECG auto-diagnosis, distributing innovative AI medical devices. |
| Company | Aisap | Shenzhen Carewell Electronics Co. (subsidiary of Lepu Medical) |
| Key Functionality | AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports. | AI-powered ECG auto-analysis and diagnosis, high accuracy (over 95%) for common cardiac abnormalities, supports 12-lead ECG data collection, rapid diagnosis in approximately 3 seconds. |
| Measurements/Pathologies Detected | Valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | Common cardiac abnormalities including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. |
| Integration | Vendor-agnostic and scalable solution; integration with existing clinical workflows, EHR/EMR, and PACS. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and AI-ECG Tracker.